Manganese (Mn) is widely used in modern industries. Occupational exposure to Mn is known to cause clinical syndromes similar, but not identical to, Parkinson's disease. This human cohort study was designed to investigate if workers exposed to Mn altered the PARK2 gene expression, leading to Mninduced neurotoxicity. Workers (n = 26) occupationally exposed to Mn were recruited from a Mn-iron (Fe) alloy smelter, and control workers (n = 20) without Mn-exposure were from an Fe smelter from Zunyi City in China. Subjects were matched with socioeconomic status and background for environmental factors. Metal concentrations were determined by atomic absorption spectrophotometry (AAS). Total RNA from the blood samples was isolated and analyzed by RT-PCR to quantify PARK2. The data showed that Mn concentrations in plasma, red blood cell (RBC) and saliva, and the cumulative Mn-exposure were about 2.2, 2.0, 1.7 and 3.0 fold higher, respectively, in Mn-exposed workers than those in control subjects (p < 0.01). The expression of PARK2 in Mn-exposed workers was significantly decreased by 42% as compared to controls (p < 0.01). Linear regression analysis further established that the expression of PARK2 mRNA was inversely correlated with Mn levels in plasma, RBC and saliva, as well as the cumulative Mn exposure (p < 0.01). Taken together, it seems likely that Mn exposure among smelters may lead to a reduced expression of PARK2, which may partly explain the Mn-induced Parkinsonian disorder.
Introduction
Manganese (Mn) is an abundant, naturally occurring element in the Earth's crust; it is a ubiquitous micronutrient required for normal growth, development and cellular homeostasis (Aschner and Aschner, 2005; Benedetto et al., 2009; Crossgrove and Zheng, 2004) . Despite being essential for metabolic functions, exposure to high doses of Mn is known to cause a neurological disease clinically known as Manganism, which is characterized by symptoms that are similar, but not identical to idiopathic Parkinson's disease (IPD) (Benedetto et al., 2009; Racette et al., 2012; Roth, 2009 ). The disease is characterized by extra-pyramidal syndrome, such as gait disturbance ("cock-walk"), bradykinesia, tremor, limb rigidity, slurred speech and mask-like face (Racette et al., 2012) . In the early stages of Mn poisoning, the symptoms could be reversible given that a reduction or elimination of Mn in the body is made possible.
The late stage of Mn poisoning, however, usually displays an irreversible damage (Cersosimo and Koller, 2006; Crossgrove and Zheng, 2004) . Therefore, the key to the treatment of Mn poisoning is to understand the mechanism by which Mn causes neurodegenerative damage.
Excessive exposure to Mn occurs mainly in occupational and environmental settings. Occupational exposure to Mn often happens among miners and smelters who are exposed to Mncontaining dust and fumes during ferroalloy smelting, mining, drycell battery production, or in manufacturing glass and ceramics Jiang et al., 2007; Lu et al., 2005; Montes et al., 2008; Qiu et al., 2013) . The environmental exposure to Mn includes sceneries such as airborne Mn due to uses of the antiknock agent methyl-cyclopentadienyl manganese tricarbonyl (MMT), the application of fungicide-containing Mn pesticides such as Maneb, and the use of permanganate as a drinking water purifier (Sikk et al., 2007; Burton and Guilarte, 2009) .
PARK2 (Parkin gene) is located on the chromosome 6 between base pairs 161, 768, 589 and 163, 148, 833 (6q25.2-q27) , and contains 12 exons surrounded by large intron regions and spans about 1.5 Mb (Matsumine et al., 2017) . Loss-of-function mutations in the PARK2 gene have been associated with the autosomal recessive juvenile parkinsonism (AR-JP), which is characterized by an early onset (Gasser, 2009; Hauser et al., 2016; Hunn et al., 2015; Illarioshkin et al., 2003; Kim et al., 2011; Mata et al., 2004; Song et al., 2016) . The PARK2 encodes the Parkin protein, an E3 ubiquitin protein ligase, and ubiquitinates a variety of substrates (Fallon et al., 2006; Sarraf et al., 2013; Trempe et al., 2009) . Parkin contains 465 amino acids, with molecular mass of about 52 kD. Parkin consists of N-terminal ubiquitin-like (UBL) domain, C-terminal RING-between-RING (RBR) domain and unique Parkin domain (UPD) (Hristova et al., 2009 ). The RBR domain comprises three RING (RING0, RING1 and RING2) domains and a 51-residue inbetween-ring (IBR) domain. Parkin-mediated ubiquitination promotes mitochondrial autophagy or degradation of target proteins (Gegg et al., 2010; Geisler et al., 2017; Poole et al., 2010; Sarraf et al., 2013) .
Our preliminary in vivo animal experiments and in vitro cell culture studies have confirmed that Mn exposure can result in a decreased expression level of PARK2 (Deng et al., 2011; Luo et al., 2016) . Since rat PARK2 is analogy to humans, we hypothesized that the PARK2 expression level may be reduced among workers who were occupationally exposed to Mn in their daily work, which may contribute, at least partially, to the mechanism of Mn-induced Parkinsonian disorder. Thus, the purpose of this human studies was to conduct a cross-sectional study in a smelter cohort in Zunyi City in China (Cowan et al., 2009a,b) , to determine the expression of PARK2 in the control and Mn-exposed groups using RT-PCR, and to establish the relationship between the expression of PARK2 and Mn levels in blood. The data from human studies shall be useful for mechanistic understanding of how Mn exposure leads to the Parkinsonian disorder. It is also possible that PARK2 expression may be used as a new exposure biomarker for Mn neurotoxicity.
Materials and methods

Study population
This cross-sectional study was conducted in Mn-exposed ferroalloy smelting workers. The ferroalloy manufacturer is located in Guizhou Province, a mountainous region in the southwest China. The workers in the control group were recruited from an iron smelting factory, which is about 20 miles away from the ferroalloy factory in Zunyi City. The smelting process and labor intensity of the two factories are similar. The demographic information on all subjects is summarized in Table 1 .
Subjects in both groups were matched with socioeconomic status (wages, education, etc.) and background environmental factors (place of residence, etc.). At the time of the interview, the subjects had no reported exposures to other toxic substances, radiation therapy or substance abuse. The subjects who took drugs that may interfere with Fe metabolism, such as vitamin D, aspirin or herbal supplements were excluded from the study. This study was approved by the Office of Clinical Investigation at the Zunyi Medical College and the Human Research Institutional Review Board at Purdue University.
Determination of airborne Mn levels in work places
The air Mn level was measured by a personal air sampler with a SKC pump (Model 224-44XR, calibrated at 2 L/min), a polyethylene tube, and a sample box with a proximal MCE filter (37 mm, pore size: 0.8 mm) was in the worker's breathing zone. Time-weighted the average concentration was calculated after each 8-h shift. Airborne Mn and Fe concentrations were determined by atomic absorption spectrophotometry (AAS) as described in our published paper (Cowan et al., 2009a (Cowan et al., , 2009b ) and summarized below.
Collection of biological samples
Written informed consent was obtained from all subjects before the interview and the physical examination. All participants agreed to use their biological samples for this study. Participants were asked to fast over night before the study. They were invited to the Zunyi Medical College (ZMC) to collect biological samples (blood and saliva). Blood samples for the analysis of Mn and Fe were placed in a heparinized tube and allowed to stand at room temperature for 30 min. After centrifuged at 600 g/min for 5 min, the supernatant and pellet were collected as the plasma and RBC, respectively. Another aliquots of blood samples (0.5 mL venous blood) were collected into an autoclave tube (pre-loaded with 0.7 mL Trizol) for gene expression analysis.
Saliva samples were collected by requiring the subject to rinse the mouth three times with distilled, deionized (DDI) water, followed by expectorating of saliva into a 2-mL test tube. All samples were stored at À80 C until analysis.
Determination of Mn or Fe concentrations in air, blood and saliva samples
Tools and glassware for AAS analysis of metal concentrations were immersed in 10% HNO 3 for 8 h and washed several times with DDI water in order to prevent metal contamination. For metals in air, the filters from the personal air sampler were removed and dried in a desiccator at room temperature for 48 h h. Filter were then digested with 5 mL of a HClO 4 -HNO 3 mixture (1: 9 vol/vol). For metals in the plasma, an aliquots (0.5 mL) of plasma were mixed with 5 mL of the digestion solution (HClO 4 : HNO 3 ; 3:7). For metals in the erythrocytes, approximately 1.5 g of precipitated blood cells was mixed with saline to a volume of 4 mL. An aliquot of the fraction (2 mL) was mixed with 10 mL of the digestion solution prior to AAS.
The saliva sample was centrifuged to remove the large particles; an aliquot (0.5 mL) of the supernatant was mixed with 0.5 mL of 100% HNO 3 for digestion. The digested sample was heated to dryness, followed by addition of 1% HNO 3 to the final volume of 0.5 mL. All samples were diluted appropriately within the range of the AAS standard curve. Mn and Fe concentrations were measured by AA240FS Varian AAS (Australia Pty Ltd.). The China National Standard Operation Protocol (GB/T16018-1995) was used for metal quantitation. The detection limits for Mn and Fe in graphite furnace AAS were 0.1 ng/mL and 0.09 ng/mL, respectively. The method used to calculate the cumulative Mn exposure was based on the following assumption: the respiratory rate among normal subjects is about 20 times per minute or 1200 times per hour; with 750 mL per inspiration and 8 h per working day and 360 days per year, a normal person breathes 2592 cubic meters a year. The respiratory rate in active workers double the rate in the resting normal subjects. Thus, the smelting workers breathe 5184 cubic meters (2592 Â 2 = 5184) per year. These values, which are multiplied by the airborne Mn level, yield the cumulative Mn exposure.
RT-PCR analysis
The transcriptional levels of mRNA encoding PARK2 and Actb (b-actin, an internal control) were quantified using qPCR. The total RNA was extracted with TRIzol (Invitrogen, Carlsbad, CA), according to the Manufacturer's recommendations, followed by purification process (Qiagen, Valencia, CA). The purified RNA was converted to cDNA with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA). The forward and reverse primer sequences for selected genes were designed with the ABI Primer Express software (Foster City, CA) and listed in Table 2 . A Power SYBR Green Master Mix (Applied Biosystems, Cheshire, UK) was used for RT-PCR analysis. The relative differences in expression between groups were expressed using cycle time (Ct) values as follows: the Ct values of the interested genes were first normalized with b-actin of the same sample, and then the relative differences between control and treatment groups were calculated and expressed as relative increases.
Statistical analysis
All demographic and personal data were abstracted from the survey questionnaires. All the data were converted to logarithms, and the symmetric distribution and linearity of the log transformed variables are valid. The data were analyzed by an Independent-Samples t Test using SPSS17.0 software. All data are expressed as mean AE SEM unless otherwise noted. Correlation coefficients was used to assess the association between the indicators. The difference between two means is considered significant, when the p value is less than 0.05.
Results
Analysis of demographic data and airborne Mn levels
Among a total of 46 subjects recruited in the study, the Mnexposed smelters were slightly younger than the controls (Table 1 ).
The control group had two females out of 20 subjects, while the Mn-exposed group had six women out of 26 subjects. Noticeably, the difference in the proportion of male to female subjects between two groups was not statistically significant. The average airborne Mn level in the smelter's working place was 0.31 mg/m 3 , which is higher than the ACGIH TLV of 0.2 mg/m 3 , and also about 1.6 fold greater than the level in the control group (p < 0.001).
Expression of PARK2 mRNA and concentrations of Mn and Fe among workers
Quantifying the expression of PARK2 mRNA in blood samples showed that the relative expression of PARK2 mRNA in the Mnexposed smelters was significantly lower than that in the control workers, about 42% of reduction (p < 0.01; Table 3 ). The distribution pattern of collected data is presented in Fig. 1 .
The AAS data further revealed that Mn concentrations in plasma, RBC, and saliva were about 2.2, 2.0, 1.7 fold higher, respectively, in the Mn-exposed smelters than in control workers (p < 0.01; Table 3 ; Fig. 2A-C) . By multiplying the airborne Mn level with estimated working days, the cumulative Mn-exposure among smelters was about 3 fold higher than that in controls (p < 0.01; Fig. 2D ).
The Fe concentrations in plasma among the Mn-exposed smelters was significantly decreased by 17% as compared to controls (p < 0.01; Fig. 3A) ; the finding was in a good agreement with our previous report (Cowan et al., 2009a) . However, Fe concentration in RBC did not change significantly in Mn-exposed workers compared with controls (p > 0.05; Fig. 3B ).
Associations between PARK2 mRNA expression and Mn and Fe levels
Altered PARK2 mRNA expression could be due to increased Mn levels in body fluids and/or decreased Fe levels in the blood. The linear regression analyses revealed that the relative PARK2 mRNA expression was statistically significantly associated with the Mn levels in plasma (r = À0.53, p < 0.01), in RBC (r = À0.32, p < 0.05), and in saliva (r = À0.65, p < 0.01) (Fig. 4A-C) . Most significantly, the PARK2 mRNA expression was decreased as the cumulative Mnexposure increased (r = À0.73, p < 0.01) (Fig. 4D) .
When the association was sought for blood Fe, it appeared that the PARK2 mRNA expression was increased as the Fe level in plasma Table 2 Forward and Reverse Primer Sequences for Selected Genes.
Gene Product
Forward Primer Reverse Primer
AAAGGCCCCTGTCAAAGAGT TTGTTGCGATCAGGTGCAAA Notes. The forward and reverse primer sequences for selected genes were designed with the ABI Primer Express software (Foster City, CA). and RBC increased; this positive correlation, however, did not reach the statistical significance (r = 0.24, p > 0.05) (Fig. 5) .
Discussion
This cross-sectional study, based on the study cohort from the manganese-iron alloy smelters, demonstrated that the PARK2 expression among Mn-exposed workers was significantly reduced by 42% as compared to control workers. More importantly, our data established an inverse association between the expression of PARK2 and Mn levels in plasms, RBC and saliva. The most significant correlation was seen between the PARK2 expression and the cumulative Mn exposure. The data provide the direct evidence to support the hypothesis that Mn-induced Parkinsonian disorder is likely associated with the altered PARK2 regulatory pathway.
The PARK2 gene encodes Parkin, a protein that is a component of tightly regulated E3 ubiquitin ligase complex. Parkin is known to promote the survival of dopaminergic neurons in both IPD and Parkinsonian disorders induced by acute exposures to neurotoxic agents (Duong et al., 2014) . A loss of function of the Parkin protein Fig. 1 . Expression of mRNA encoding PARK2 in blood. Blood samples were collected from smelters or control workers in Zunyi, China. Lines represent the group mean and dots represent each individual determinant; n = 20 for controls and n = 26 for Mn-exposed smelters. has been shown to lead to the dopaminergic cell death in IPD (Romani-Aumedes et al., 2014) . Studies on drosophila demonstrate that co-expression of human Parkin (hParkin) prevents against toxicities induced by over-expression of dNrdp1; the latter causes the loss of dopaminergic neurons in brain (Tan et al., 2011) . While the mechanism remains unclear, Parkin is thought to be genetically linked to the glial cell line-derived neurotrophic factor receptor RET (Rearranged during Transfection); by converging with the RET signaling cascade, the Parkin controls mitochondrial structure and function, and maintains the integrity of dopaminergic neurons in substantia nigra and their innervation in striatum (Corti and Brice, 2013; Meka et al., 2015) . In cell models, expression of Parkin can restore the mitochondrial function in DNF/RET-deficient cells (Meka et al., 2015) . Literature data also show that the cellpermeable Parkin can compensate for intrinsic limitations in the Parkin response and provide a therapeutic strategy to augment Parkin activity in vivo (Duong et al., 2014) . Toxicologically, induction of Parkin expression can protect striatal dopaminergic terminals against methamphetamine (METH)-induced neurotoxicity (Liu et al., 2013a) . Logically, a reduction in Parkin expression, as observed in this study, could weaken the protective effect of Parkin in the pathoetiology of Parkinson's disease or related disorders.
Our previous studies show that subchronic exposure to Mn in rats causes a significant decrease of the PARK2 expression in striatum, cortex, and blood cells, accompanying with a declined motor activity among Mn-exposed animals (Deng et al., 2011; Luo et al., 2016) . Tyrosine hydroxylase (TH) immunohistochemical staining further demonstrate that Mn decreases dopaminergic neurons in substantia nigra, which is possibly associated with the decreased PARK2 (Luo et al., 2016) . Our in vitro studies using dopaminergic PC12 cells also show that the reduced dopamine level is associated with the down-regulated PARK2 expression (Qiu et al., 2013) . The current results from the Mn-exposed human cohort appeared to verify these animal data and demonstrated that the relative PARK2 mRNA expression was indeed decreased following occupational exposure to Mn.
A clear inverse association between the PARK2 expression and Mn levels in plasma, RBC, and saliva is evident; more impressive is a great correlation of the PARK2 expression with the cumulative Mn exposure. Thus, the PARK2 expression seemed likely to be sensitive to the Mn exposure. The question as to how the change in PARK2 expression may ultimately contribute to the clinically defined manganism remains elusive. Since the clinical syndromes of manganism overlap, to some degree, with the IPD, it is highly likely that Mn-induced alteration in PARK2 expression may partly underlie some of the clinical Parkinsonian signs and symptoms observed in manganism patients. Noticeably also, a recent finding from this group has shown that subacute, low-level Mn exposure indeed disrupts multiple neurotransmitter systems including dopaminergic system in a rat model (O'Neal et al., 2014) .
Research efforts on searching for an effective biomarker for Mn intoxication are plentiful (O'Neal and Zheng, 2015) . While the blood Mn level could partly differentiate groups of occupational Mn exposure from those non-Mn exposed controls, the large variation prevents it from being used as a reliable biomarker for individual monitoring (O'Neal and Zheng, 2015; Smith et al., 2007) . One earlier study among welders shows that saliva Mn levels are higher in welders than in control subjects (Wang et al., 2008) ; but the larger variation in saliva than in serum renders the saliva assessment less applicable in real-life assessment. Mn levels in bone are the most promising approach for noninvasive assessment of body burden of Mn for cumulative exposure (Liu et al., 2013b (Liu et al., , 2017 . However, the detection system has not yet been made available for general populational research. In our previous study, we have attempted to establish the manganese-iron ratio (MIR) in blood as the biomarker for Mn health effect assessment (Cowan et al., 2009a,b) . From the same cohort, we have also investigated the expression of some iron transport proteins such as DMT1, transferrin and hepcidin . But then again the concept has not yet been further verified in larger study cohorts. The current study has identified an excellent correlation between the reduction of PARK2 and the cumulative Mn exposure. Thus, the possibility to use blood PARK2 as the useful biomarker for Mn exposure deserves the future in-depth investigation.
In summary, this study demonstrated that PARK2 expression decreased as the cumulative Mn exposure increases among smelters who were occupationally exposed to Mn. The finding suggests that Mn-induced Parkinsonian syndromes may be due partly to the altered PARK2 expression. Furthermore, the possibility to use the altered PARK2 expression in blood as a biomarker for Mn exposure assessment deserves further investigation.
